All individual studies that were included in the GWASmeta-analyses for AMH, stroke and diabetes, and the UKBiobank cohort, receivedethical approval from qualified institutional boards and all included studyparticipants provided informed consent. This evidence concerns the gene AMH and stroke disorder.